← Back to Clinical Trials
Recruiting NCT05193136

Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Sleep Hygiene
Sponsor National Hospital Organization Minami Kyoto Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 120
Sex ALL
Min Age 20 Years
Max Age N/A
Start Date 2021-12-10
Completion 2025-12

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

We aim to clarify the relationship between sleep hygiene and the onset of sarcopenia or cognitive dysfunction using sleep time, arousal, and sleep quality as indicators in COPD or IPF patients, and clarify the effects of sleep hygiene on disease progression and life prognosis.

Eligibility Criteria

Inclusion Criteria: * Subjects with COPD or IPF. Exclusion Criteria: * Subjects who have been hospitalized for exacerbation of respiratory failure within 1 month of study participation * Subjects who have already been diagnosed with sarcopenia or cognitive dysfunction * Subjects receiving long-term oxygen therapy (LTOT) or non-invasive ventilation therapy (NIV) * Subjects with obstructive sleep apnea who are indicated for continuous positive airway pressure (CPAP) * Subjects with severe complications such as cardiovascular disease, liver disease, renal disease, malignancy, and neurological disease.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}